Veracyte | VCYT - 营业利润



金融业
股票价格
USD
资产
USD 1.44B
现金及等价物
USD 263.14M
销售成本
USD 38.49M
流动资产
USD 522.18M
流动负债
USD 56.12M
债务
USD 39.65M
EBIT
USD 19.08M
EBITDA
USD 42.8M
员工
824
EPS每股收益
USD 0.52
股本和储备
USD 1.34B
销售毛利
USD 101.16M
债务利息支出
USD 2K
利息收入
USD 3.48M
贷款资金
USD 0
市值
USD 3.53B
净收入
USD 28.71M
营业费用
USD 119.99M
营业利润
USD 19.08M
普通股股本
USD 79.79M
PE价格收益
24.89
税前利润
USD 29.97M
销售收入
USD 139.07M
销售和管理费用
USD 50.84M
股票
USD 21.42M
贸易债权人
USD 6.91M
应收帐款人
USD 50.11M


营业利润 更改 日
Agenus USD 14.4M 19.26M 2025-12
Agilent USD 353M 90M 2025-12
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -141.26M 182.07M 2026-03
Bruker USD 10.2M 66.1M 2026-03
Heron Therapeutics USD 38K 3.83M 2025-12
Illumina USD 239M 17M 2026-03
Intrexon USD -60.84M 26.62M 2024-06
Karyopharm Therapeutics USD -17.84M 13.44M 2025-12
Laboratory Of America USD 410.1M 28.1M 2026-03
Ligand Pharmaceuticals USD 60.33M 40.29M 2026-03
Myriad Genetics USD -3M 20.3M 2025-12
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Roche Holding CHF 9.56B 3.8B 2025-12
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Siemens EUR 2.57B 3M 2025-12
Sonic Healthcare AUD 435.76M 193.66M 2024-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Veracyte USD 19.08M 5.55M 2026-03
Waters USD 148M 122.52M 2026-03